AR and benign prostatic hyperplasia: Given the critical importance of AR transcriptional control in various diseases such as androgen insensitivity syndrome, benign prostatic hyperplasia, and prostate cancer (70), intriguingly, this isoform may potentially be a target for therapy not only for SBMA but also for other AR-related conditions.